Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Whole-genome sequencing of longitudinal tumor pairs representing transformation of follicular lymphoma to high-grade B cell lymphoma with MYC and BCL2 rearrangements (double-hit lymphoma) identified coding and noncoding genomic alterations acquired during lymphoma progression. Many of these transformation-associated alterations recurrently and focally occur at topologically associating domain resident regulatory DNA elements, including H3K4me3 promoter marks located within H3K27ac super-enhancer clusters in B cell non-Hodgkin lymphoma. One region found to undergo recurrent alteration upon transformation overlaps a super-enhancer affecting the expression of the PAX5/ZCCHC7 gene pair. ZCCHC7 encodes a subunit of the Trf4/5-Air1/2-Mtr4 polyadenylation-like complex and demonstrated copy number gain, chromosomal translocation and enhancer retargeting-mediated transcriptional upregulation upon lymphoma transformation. Consequently, lymphoma cells demonstrate nucleolar dysregulation via altered noncoding 5.8S ribosomal RNA processing. We find that a noncoding mutation acquired during lymphoma progression affects noncoding rRNA processing, thereby rewiring protein synthesis leading to oncogenic changes in the lymphoma proteome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 3′-end maturation of 5.8S rRNA is a multistep process involving handover between subunits of the RNA exosome (depicted as a “Pacman” symbol in Fig. 7A) [69, 70].”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941 · cited 2×
“2c) 16,24,32–34 .”
BackgroundFrequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Chapuy, B., McKeown, M. R., Lin, C. Y., Monti, S., Roemer, M. G. M., Qi, J., Rahl, P. B., Sun, H. H., Yeda, K. T., Doench, J. G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.003 · Cited by 735 · cited 1×
“44,45), and we suspected that ‘enhancer retargeting (ER),’ whereby functional loss of a promoter results in subsequent preferential targeting of a different promoter 35,45 , could occur following aSHM at promoter regions during lymphoma progression.”
BackgroundRNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity
Pefanis, E., Wang, J., Rothschild, G., Lim, J., Kazadi, D., Sun, J., Federation, A., Chao, J., Elliott, O., Liu, Z.-P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.034 · Cited by 464 · cited 2×
“Furthermore, sequencing of DHL samples has shown that ZCCHC7 represents a frequent translocation partner of MYC 50,51 (such a translocation was also identified in one of our DHL samples separate from the longitudinal cohort, patient 11; Extended Data Fig.”
BackgroundSelf-citationNoncoding RNA transcription targets AID to divergently transcribed loci in B cells
Pefanis, E., Wang, J., Rothschild, G., Lim, J., Chao, J., Rabadan, R., Economides, A. N., & Basu, U. (2014) · Nature · doi:10.1038/nature13580 · Cited by 201 · cited 1×
“…performed in mouse B cells show sense/antisense transcription overlapping the Pax5 promoter region and deletion of RNA exosome activity ( DIS3 C / C B cells) leading to accumulation of these sense/anti-sense transcripts, a mechanism resulting in increased AID-mediated mutagenesis 12,47,48 .”
BackgroundSelf-citationEnhancer release and retargeting activates disease-susceptibility genes
Oh, S., Shao, J., Mitra, J., Xiong, F., D’Antonio, M., Wang, R., Garcia-Bassets, I., Ma, Q., Zhu, X., Lee, J.-H., et al. (2021) · Nature · doi:10.1038/s41586-021-03577-1 · Cited by 148
Research works printed but not linked: 65
- Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413–442 (2022). · DOI · Paper page
- Schatz, D. G. & Ji, Y. Recombination centres and the orchestration of V(D)J recombination. Nat. Rev. Immunol. 11, 251–263 (2011). · DOI · Paper page
- Alt, F. W., Zhang, Y., Meng, F.-L., Guo, C. & Schwer, B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152, 417–429 (2013). · DOI · Paper page
- Keim, C., Kazadi, D., Rothschild, G. & Basu, U. Regulation of AID, the B-cell genome mutator. Genes Dev. 27, 1–17 (2013). · DOI · Paper page
- Yeap, L.-S. & Meng, F.-L. Cis- and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification. Adv. Immunol. 141, 51–103 (2019). · DOI
- Sun, J., Rothschild, G., Pefanis, E. & Basu, U. Transcriptional stalling in B-lymphocytes: a mechanism for antibody diversification and maintenance of genomic integrity. Transcription 4, 127–135 (2013). · DOI
- Robbiani, D. F. & Nussenzweig, M. C. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu. Rev. Pathol. 8, 79–103 (2013). · DOI · Paper page
- Shaffer, A. L. III, Young, R. M. & Staudt, L. M. Pathogenesis of human B cell lymphomas. Annu. Rev. Immunol. 30, 565–610 (2012). · DOI · Paper page
- Feng, Y., Seija, N., Di Noia, J. M. & Martin, A. AID in antibody diversification: there and back again. Trends Immunol. 41, 586–600 (2020). · DOI · Paper page
- Meng, F.-L. et al. Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability. Cell 159, 1538–1548 (2014). · DOI · Paper page
- Qian, J. et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159, 1524–1537 (2014). · DOI · Paper page
- Wang, Q. et al. Epigenetic targeting of activation-induced cytidine deaminase. Proc. Natl Acad. Sci. USA 111, 18667–18672 (2014). · DOI
- Casellas, R. et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat. Rev. Immunol. 16, 164–176 (2016). · DOI · Paper page
- Panea, R. I. et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood 134, 1598–1607 (2019). · DOI · Paper page
- Horning, S. J. & Rosenberg, S. A. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N. Engl. J. Med. 311, 1471–1475 (1984). · DOI · Paper page
- Bastion, Y. et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J. Clin. Oncol. 15, 1587–1594 (1997). · doi:10.1200/jco.1997.15.4.1587
- Gallagher, C. J. et al. Follicular lymphoma: prognostic factors for response and survival. J. Clin. Oncol. 4, 1470–1480 (1986). · DOI · Paper page
- Davies, A. J. et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br. J. Haematol. 136, 286–293 (2007). · DOI
- Gonzalez-Rincon, J. et al. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. PLoS ONE 14, e0212813 (2019). · DOI
- Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat. Genet. 46, 176–181 (2014). · DOI · Paper page
- Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130–140 (2014). · DOI · Paper page
- Hilton, L. K. et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood 134, 1528–1532 (2019). · DOI
- Kridel, R. et al. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med. 13, e1002197 (2016). · DOI · Paper page
- Tsukamoto, T. et al. High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif. Sci. Rep. 7, 14039 (2017). · DOI
- Boughan, K. M. & Caimi, P. F. Follicular lymphoma: diagnostic and prognostic considerations in initial treatment approach. Curr. Oncol. Rep. 21, 63 (2019). · doi:10.1007/s11912-019-0808-0
- Dreyling, M. et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 298–308 (2021). · DOI · Paper page
- Cleary, M. L. & Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA 82, 7439–7443 (1985). · DOI · Paper page
- Liu, D. & Lieber, M. R. The mechanisms of human lymphoid chromosomal translocations and their medical relevance. Crit. Rev. Biochem. Mol. Biol. 57, 227–243 (2022). · DOI
- Kämpjärvi, K. et al. Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia. Oncotarget 6, 1884–1888 (2015). · DOI
- Morin, R. D. et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 122, 1256–1265 (2013). · DOI · Paper page
- Senigl, F. et al. Topologically associated domains delineate susceptibility to somatic hypermutation. Cell Rep. 29, 3902–3915 (2019). · DOI
- Bal, E. et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature 607, 808–815 (2022). · DOI · Paper page
- Ye, X. et al. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas. J. Exp. Med. 218, e20200573 (2021). · DOI
- Mertz, T. M., Collins, C. D., Dennis, M., Coxon, M. & Roberts, S. A. APOBEC-induced mutagenesis in cancer. Annu. Rev. Genet. 56, 229–252 (2022). · DOI
- Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013). · DOI · Paper page
- Andrey, G. & Mundlos, S. The three-dimensional genome: regulating gene expression during pluripotency and development. Development 144, 3646–3658 (2017). · DOI · Paper page
- Lieberman-Aiden, E. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289–293 (2009). · DOI · Paper page
- Fabbri, G. et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J. Exp. Med. 210, 2273–2288 (2013). · DOI · Paper page
- Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519–524 (2015). · DOI · Paper page
- Liu, M. et al. Methodologies for improving HDR efficiency. Front. Genet. 9, 691 (2018). · DOI · Paper page
- Laffleur, B. et al. Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells. Nat. Genet. 53, 230–242 (2021). · DOI · Paper page
- Pefanis, E. & Basu, U. RNA exosome regulates AID DNA mutator activity in the B cell genome. Adv. Immunol. 127, 257–308 (2015). · DOI
- Rogozin, I. B. & Diaz, M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 172, 3382–3384 (2004). · DOI · Paper page
- Chong, L. C. et al. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. Blood Adv. 2, 2755–2765 (2018). · DOI
- Bertrand, P. et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 21, 515–523 (2007). · DOI
- Rodriguez-Hernandez, G. et al. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat. Commun. 10, 5563 (2019). · DOI
- Swaminathan, S. et al. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia. Nat. Immunol. 16, 766–774 (2015). · DOI · Paper page
- Kilchert, C., Wittmann, S. & Vasiljeva, L. The regulation and functions of the nuclear RNA exosome complex. Nat. Rev. Mol. Cell Biol. 17, 227–239 (2016). · DOI · Paper page
- Puno, M. R., Weick, E. M., Das, M. & Lima, C. D. SnapShot: the RNA exosome. Cell 179, 282–282.e1 (2019). · DOI · Paper page
- Allmang, C., Mitchell, P., Petfalski, E. & Tollervey, D. Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res. 28, 1684–1691 (2000). · DOI · Paper page
- LaCava, J. et al. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 121, 713–724 (2005). · DOI · Paper page
- Lubas, M. et al. Interaction profiling identifies the human nuclear exosome targeting complex. Mol. Cell 43, 624–637 (2011). · DOI · Paper page
- Tafforeau, L. et al. The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors. Mol. Cell 51, 539–551 (2013). · DOI · Paper page
- Forester, C. M. et al. Revealing nascent proteomics in signaling pathways and cell differentiation. Proc. Natl Acad. Sci. USA 115, 2353–2358 (2018). · DOI · Paper page
- Panda, A. C., Martindale, J. L. & Gorospe, M. Polysome fractionation to analyze mRNA distribution profiles. Bio Protoc. 7, e2126 (2017). · DOI · Paper page
- Carlotti, E. et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 113, 3553–3557 (2009). · DOI
- Marcel, V. et al. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24, 318–330 (2013). · DOI · Paper page
- Pelletier, J., Thomas, G. & Volarevic, S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat. Rev. Cancer 18, 51–63 (2018). · DOI · Paper page
- Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41–44 (2020). · DOI · Paper page
- Mumbach, M. R. et al. HiChIRP reveals RNA-associated chromosome conformation. Nat. Methods 16, 489–492 (2019). · DOI · Paper page
- Rothschild, G. et al. Noncoding RNA transcription alters chromosomal topology to promote isotype-specific class switch recombination. Sci. Immunol. 5, eaay5864 (2020). · DOI
- Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015). · DOI · Paper page
- Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016). · DOI · Paper page
- Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220–1222 (2016). · doi:10.1093/bioinformatics/btv710
- Rao, S. S. P. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014). · DOI · Paper page
Cited by
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Self-citation
Metadata
- Authors
- Leeman-Neill, R. J., Song, D., Bizarro, J., Wacheul, L., Rothschild, G., Singh, S., Yang, Y., Sarode, A. Y., Gollapalli, K., Wu, L., Zhang, W., Chen, Y., Lauring, M. C., Whisenant, D. E., Bhavsar, S., Lim, J., Swerdlow, S. H., Bhagat, G., Zhao, Q., Berchowitz, L. E., Lafontaine, D. L. J., Wang, J., & Basu, U.
- ORCID
- Venue
- Nature Genetics
- Published
- 2023-12
- Volume
- 55
- Issue
- 12
- Pages
- 2160-2174
- ISSN
- 1061-4036
- 1546-1718
- Cited by
- 49
- References
- 7
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 3 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. https://app.cochat.ai/papers/10.1038/s41588-023-01561-1
- The paper
- Leeman-Neill, R. J., Song, D., Bizarro, J., Wacheul, L., Rothschild, G., Singh, S., Yang, Y., Sarode, A. Y., Gollapalli, K., Wu, L., Zhang, W., Chen, Y., Lauring, M. C., Whisenant, D. E., Bhavsar, S., Lim, J., Swerdlow, S. H., Bhagat, G., Zhao, Q., . . . Basu, U. (2023). Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression. Nature Genetics. https://doi.org/10.1038/s41588-023-01561-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.